ICUI - ICU Medical, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
3.96B
Enterprise Value 3
3.66B
Trailing P/E
56.55
Forward P/E 1
27.36
PEG Ratio (5 yr expected) 1
1.50
Price/Sales (ttm)
3.07
Price/Book (mrq)
2.95
Enterprise Value/Revenue 3
2.83
Enterprise Value/EBITDA 6
16.01

Trading Information

Stock Price History

Beta (5Y Monthly) 0.90
52-Week Change 3-21.11%
S&P500 52-Week Change 325.98%
52 Week High 3259.72
52 Week Low 3148.89
50-Day Moving Average 3185.63
200-Day Moving Average 3184.39

Share Statistics

Avg Vol (3 month) 3188.86k
Avg Vol (10 day) 3158.22k
Shares Outstanding 520.67M
Float 19.21M
% Held by Insiders 17.03%
% Held by Institutions 194.20%
Shares Short (Dec 30, 2019) 4773.51k
Short Ratio (Dec 30, 2019) 44.75
Short % of Float (Dec 30, 2019) 45.64%
Short % of Shares Outstanding (Dec 30, 2019) 43.74%
Shares Short (prior month Nov 28, 2019) 4855.32k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 23:2
Last Split Date 3Mar 17, 2002

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 5.66%
Operating Margin (ttm)11.76%

Management Effectiveness

Return on Assets (ttm)5.96%
Return on Equity (ttm)5.62%

Income Statement

Revenue (ttm)1.29B
Revenue Per Share (ttm)62.74
Quarterly Revenue Growth (yoy)-6.00%
Gross Profit (ttm)570.03M
EBITDA 228.5M
Net Income Avi to Common (ttm)73.04M
Diluted EPS (ttm)3.39
Quarterly Earnings Growth (yoy)12,029.20%

Balance Sheet

Total Cash (mrq)338.1M
Total Cash Per Share (mrq)16.35
Total Debt (mrq)36.94M
Total Debt/Equity (mrq)2.76
Current Ratio (mrq)3.70
Book Value Per Share (mrq)64.84

Cash Flow Statement

Operating Cash Flow (ttm)102.99M
Levered Free Cash Flow (ttm)96.28M